XML 66 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
9 Months Ended
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Fair value, beginning balance $ 767 $ 788  
Additions 97 0  
Changes in estimated fair value 71 52  
Payments (106) (85)  
Fair value, ending balance 829 755  
Current liability     $ 140
Contingent consideration 829 $ 755 829
Sanofi Pasteur      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Fair value, beginning balance 625    
Fair value, ending balance 637    
Contingent consideration $ 625   $ 637
Contingent consideration, measurement input, discount rate (as percent)     0.115
Measurement Input, Discount Rate | Sanofi Pasteur      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Contingent consideration, measurement input, discount rate (as percent)     0.08